Patients Undergoing Laparoscopic Surgery Clinical Trial
Official title:
Feasibility and Safety Study of LapSpace, A Novel Laparoscopic Surgical Instrument
In order to help the surgeons to clearly visualize their target operating area and create an
optimal operative field throughout the procedure, the device owners have developed a new
class of inflatable laparoscopic retractors for both bowel and organ specific retraction with
load bearing bore by an inflatable reinforced material that is atraumatic, biocompatible, and
are self-retained, i.e. require no personnel to maintain them post-placement.
Specifically, the device owners menu of designs hold a range of 50 - 100 % of the bowels and
support at minimum 6 lbs in the vertical direction. All the device owners devices enter the
abdominal cavity through a conventional 10mm incision. The pressure within the inflatable
tubes of the device will not be above 15 mmHg, which is the current pressure used to
insufflate the patient's abdomen with carbon dioxide (CO2). The devices are able to retract
up to 10 cm of the bowels in any direction within the coronal plane and retract the bowels
10cm upward, towards the abdominal wall. Finally, the invention here-in described can be
manipulated easily to provide retraction of specific organs, including, liver, bladder,
uterus, etc.
The device has been approved by the FDA for clinical use (FDA Registered) and the purpose of
this study is to evaluate the device in laparoscopic operations for safety and feasibility.
The field of laparoscopy has been growing exponentially during the past decade because of its
tremendous benefits over open surgery such as minimal incisions, lesser post-operative
trauma, quicker recovery, lesser scarring, reduced hospital stay and lower infection rates.
It is clear that the success of any laparoscopic surgery lies on the optimal exposure of the
operative site. Surgeons and assistants are required to tightly strap the patients on the
surgical bed, continuously change the patient's position in order to use gravity to hold the
bowels out of the way and finally result in manual over manipulation of bowels and organs
using graspers in order to achieve the optimal exposure of their site. However, small bowels
or organs cannot be held back efficiently using these techniques and slide continuously into
the operating area.
In practice, the obstruction of the surgeons' visual field and the excessive manipulation of
the bowels cause unintentional injuries, bleeding, bruising, hematoma and perforations that
might require patients to undergo
additional surgeries because of scar tissue formation. The U.S market for scar tissue
prevention products is estimated at a staggering $2-3 billion. Furthermore, the current
standard of clinical care forces surgeons to add procedural steps in the operation in order
to minimize possible complications. However, these extra steps further extend the duration of
the operations, leading to a loss of money and reliability on behalf of the hospitals.
The device owners bowel retractors eliminate the time-consuming mobilization of the small
intestines while they stabilize the bowels, allowing for a clear view of the operative site.
Given the increased demand of laparoscopic surgeries in which the device owners device is
helpful (approaching 5 million surgeries per year) the time saved after only a few uses of
the device owners device is significant enough to benefit hospitals in allowing them to host
another surgery that is waiting in the backlog. The device owners devices, thus, are not only
beneficial for the patients since they minimize trauma and complications but also highly
profitable for the hospitals.
The proposed device contains a variety of novel features, which are enumerated henceforth.
The device owners device will be inflatable and will have inflatable "ribs" at the grasping
terminal of the device. The ribs will work in tandem with the mechanism of inflation in order
to adequately grasp the desired portion of bowel in the abdominal cavity. In addition, the
device owners device will be firmly attached to a solid steel center rod, with which the
surgeon can maneuver the device. The solid rod will also contain a sliding seal, such that
after the device has been inserted into the abdominal cavity, the seal can be slid into place
and will serve to effectively anchor the device on the abdominal wall. On the end of the rod
near the surgeon, there will be an attached handle with a trigger. This handle system will be
used to inflate the device by pulling the trigger and allowing compressed air through the
central rod. The handle will also be the point of contact between the surgeon's hand and the
device owners device, allowing him further maneuverability throughout the procedure.
The product is a bowl-shaped device that is intended to be used as an organ or bowel
retractor in laparoscopic surgeries. This device consists of a central, hollow rod made of
steel that has a straight proximal end and a curved distal end. The aforementioned distal end
of the device has an inflatable portion, the material for which encircles the central rod.
The inflatable portion also contains tubular projections which emanate from where the
material contacts the central rod out to the edges of the inflatable portion. These
projections are denoted henceforth as "ribs". The inflatable material is a biocompatible
polymer that can hold sufficient tension and pressure for the application of laparoscopic
surgery. The ribs curve inwards, which create a bowl-like structure when fully inflated and
deployed. Each of the ribs are connected to the central rod and to each adjacent rib via
membrane, which is connected medially to the central shaft all along the distal, curved end.
This creates a functional inflatable endoskeleton to support the bowels and organs that will
be in contact with this device during laparoscopic surgery. The amount of inflation of the
device can be modulated by the surgeon, by increasing or decreasing the inflation pressure as
desired by adding more compressed air or withdrawing compressed air, respectively.
The proximal end of the central rod will have a handle grip with a trigger attached to it.
There will be an inlet for where a canister of compressed air will be positioned, such that
when the trigger is depressed by the surgeon, air will flow down the length of the hollow
central rod and inflate the device. The handle and grip
will be attached such that the surgeon can deftly maneuver and retract the device after it
has been inserted in the patient.
The central rod will further house a sealing mechanism that can slide along the length of the
rod, from the proximal handle to the distal end. This sliding seal will be affixed in place
to the abdominal wall, allowing for a functional anchor and pivot point about which the
retractor has many degrees of freedom with respect to movement, while still being supported
by the seal to the patient's abdomen. A surgeon can choose to use a trocar in lieu of a
sliding seal, which will have to be placed on the central before the attachment of the handle
grip.
After the device is in place after being fully inflated, it has the ability to grasp and hold
the bowel in its concave interior region. The ribs help maintain the accurate shape and
rigidity of the inflated portion, and thus will allow the device to remain flush against the
bowel during retraction. The surgeon will then
presumably pull the central rod to a more beneficial location, such that the operative field
is no longer obstructed by the device. The surgeon can then affix the device to a surgical
bed clamp, so as to free the surgeon from holding the device in place throughout the duration
of the procedure.
As of now, the device is to be utilized for laparoscopic abdominal surgical procedures.
However, a similar or slightly modified product could be used for gynecological procedures as
well, and would aid in the retraction or holding of pelvic or lower abdominal organs in those
procedures. In addition, future variations of the design could be applicable to upper
abdominal or cardiothoracic procedures as well. This device could also potentially be used in
organ resection as well as retraction, in that modifications to the device could potentially
allow it to clear the operative field while simultaneously being involved in organ excision.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03371953 -
Evaluation of Atracurium-vecuronium Combination in Laparosocpic Surgery
|
Phase 4 | |
| Recruiting |
NCT06342570 -
Quantitative Analysis of EEG Changes in Response to Nociception
|